A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study

Kazumasa Yamagishi1, Aaron R Folsom, Wayne D Rosamond

  • 1Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S Second Street, Suite 300, Minneapolis, MN 55454-1015, USA.

European Heart Journal
|March 31, 2009
PubMed

Insights

Genetic variations on chromosome 9p21, specifically the GG genotype of rs10757274, are linked to higher heart failure (HF) risk in white individuals. This 9p21 genetic marker also shows a weak association with carotid atherosclerosis.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology
  • Molecular Biology

Background:

  • Polymorphisms on chromosome 9p21 are established risk factors for coronary heart disease (CHD).
  • Limited research has explored the association of these 9p21 polymorphisms with heart failure (HF), stroke, and subclinical atherosclerotic diseases.

Purpose of the Study:

  • To investigate the association between chromosome 9p21 polymorphisms and non-coronary atherosclerotic diseases.
  • To determine if 9p21 polymorphisms, known for CHD risk, are also associated with HF, stroke, and subclinical atherosclerosis.

Main Methods:

  • Analysis of 4018 African-American and 11 085 white participants from the Atherosclerosis Risk in Communities Study.
  • Examination of rs10757274 and rs2383206 polymorphisms in relation to incident HF, ischemic stroke, prevalent carotid atherosclerosis, and peripheral artery disease (PAD).

Main Results:

  • The GG genotype of rs10757274 was associated with increased HF risk in white participants, independent of known CHD links.
  • A weak association was observed between the GG genotype of rs10757274 and increased carotid atherosclerosis risk among whites.
  • No significant associations were found for ischemic stroke or PAD in relation to these polymorphisms.

Conclusions:

  • The GG genotype of rs10757274 on chromosome 9p21 is associated with increased heart failure risk in whites.
  • This genetic variant shows weak or no association with other major atherosclerosis outcomes like stroke and PAD.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...